Tuesday, December 8, 2015

Pfizer-Allergan Merger Marries Companies With History Of Fraud

fiercehealthpayer antifraud
Companies have paid a combined $4.5 Billion in federal settlements
December 7, 2015 | By 
The recent merger between Pfizer and Allergen is getting plenty of attention for its $160 billion pricetag, but one healthcare attorney wonders if fraud and corruption are part of each company's "corporate DNA."
In an editorial posted to Forbes.com, Erica Kelton, a partner with Phillips & Cohen LLP, underscores the fact that together, the two pharmaceutical giants have paid nearly $4.5 billion to settle federal fraud allegations, along with six criminal pleas and four corporate integrity agreements dating back to 2004.
In 2009, Pfizer paid $2.3 billion for off-label marketing of an anti-inflammatory drug, Bextra. At the time, it was the largest healthcare fraud settlement in the history of the Department of Justice, largely because Pfizer's indiscretions occurred while it was negotiating another corporate integrity agreement of off-label use of Neurontin, Kelton writes
Since then, Allergen and Pfizer have agreed to settlements ranging from $1.7 million to $491 million. In October, an Allergen subsidiary agreed to pay $125 million for paying kickbacks to physicians to prescribe certain drugs, leading to thesurprising arrest of one of the company's executives.
"If nothing else, the merger of Pfizer and Allergan should be regarded as an invitation to whistleblowers around the world to continuously scrutinize the giant company's business practices," Kelton writes.
For more:
- read the Forbes post


Thank You Mr Sweeny and FHPAF.
at

No comments:

Post a Comment

All standard cautions apply. Your milage may vary.

So Try to be an Adult, [no carpet F bombings, Pron, open threats, etc.] and not a Psychiatrist, about it. Google account, for now, is no longer required to comment, but moderation is in effect.